Neoadjuvant chemotherapy modifies thyroid function in postmenopausal but not premenopausal women with breast cancer
Author:
Ramírez-Expósito María Jesús,
Carrera-González María Pilar,
Martínez-Martos José ManuelORCID
Reference25 articles.
1. Suhane S and Ramanujan VK: Thyroid hormone differentially modulates warburg phenotype in breast cancer cells. Biochem Biophys Res Commun 414(1): 73-78, 2011. PMID: 3207240, DOI: 10.1016/j.bbrc.2011.09.024
2. Burke RE and McGuire WL: Nuclear thyroid hormone receptors in a human breast cancer cell line. Cancer Res 38(11 Pt 1): 3769-3773, 1978. PMID, DOI:
3. Hall LC, Salazar EP, Kane SR and Liu N: Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol 109(1-2): 57-66, 2008. PMID, DOI: 10.1016/j.jsbmb.2007.12.008
4. Tang HY, Lin HY, Zhang S, Davis FB and Davis PJ: Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145(7): 3265-3272, 2004. PMID, DOI: 10.1210/en.2004-0308
5. Dinda S, Sanchez A and Moudgil V: Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 21(5): 761-768, 2002. PMID, DOI: 10.1038/sj.onc.1205136